Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$0.49−0.01 (-1.96%)

Close on Nov 13, 2026Market cap $33.74MP/E –Yield –

Telomir Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Telomir Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?